These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23134341)

  • 21. Ubiquitin-dependent degradation of interferon regulatory factor-8 mediated by Cbl down-regulates interleukin-12 expression.
    Xiong H; Li H; Kong HJ; Chen Y; Zhao J; Xiong S; Huang B; Gu H; Mayer L; Ozato K; Unkeless JC
    J Biol Chem; 2005 Jun; 280(25):23531-9. PubMed ID: 15837792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Notch-induced E2A degradation requires CHIP and Hsc70 as novel facilitators of ubiquitination.
    Huang Z; Nie L; Xu M; Sun XH
    Mol Cell Biol; 2004 Oct; 24(20):8951-62. PubMed ID: 15456869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The N-terminal extension of UBE2E ubiquitin-conjugating enzymes limits chain assembly.
    Schumacher FR; Wilson G; Day CL
    J Mol Biol; 2013 Nov; 425(22):4099-111. PubMed ID: 23871895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-degradative ubiquitination of the Notch1 receptor by the E3 ligase MDM2 activates the Notch signalling pathway.
    Pettersson S; Sczaniecka M; McLaren L; Russell F; Gladstone K; Hupp T; Wallace M
    Biochem J; 2013 Mar; 450(3):523-36. PubMed ID: 23252402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin.
    Shenoy SK; McDonald PH; Kohout TA; Lefkowitz RJ
    Science; 2001 Nov; 294(5545):1307-13. PubMed ID: 11588219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIF-1alpha and EPAS ubiquitination mediated by the VHL tumour suppressor involves flexibility in the ubiquitination mechanism, similar to other RING E3 ligases.
    Paltoglou S; Roberts BJ
    Oncogene; 2007 Jan; 26(4):604-9. PubMed ID: 16862177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional regulation of MyD88-activated interferon regulatory factor 5 by K63-linked polyubiquitination.
    Balkhi MY; Fitzgerald KA; Pitha PM
    Mol Cell Biol; 2008 Dec; 28(24):7296-308. PubMed ID: 18824541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TRIAD1 is negatively regulated by the MDM2 E3 ligase.
    Bae S; Jung JH; An IS; Kim OY; Lee MJ; Lee JH; Park IC; Lee SJ; An S
    Oncol Rep; 2012 Nov; 28(5):1924-8. PubMed ID: 22940738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights into the conformational dynamics of the E3 ubiquitin ligase CHIP in complex with chaperones and E2 enzymes.
    Graf C; Stankiewicz M; Nikolay R; Mayer MP
    Biochemistry; 2010 Mar; 49(10):2121-9. PubMed ID: 20146531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sortilin turnover is mediated by ubiquitination.
    Dumaresq-Doiron K; Jules F; Lefrancois S
    Biochem Biophys Res Commun; 2013 Mar; 433(1):90-5. PubMed ID: 23485461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zebrafish IRF1 regulates IFN antiviral response through binding to IFNϕ1 and IFNϕ3 promoters downstream of MyD88 signaling.
    Feng H; Zhang YB; Zhang QM; Li Z; Zhang QY; Gui JF
    J Immunol; 2015 Feb; 194(3):1225-38. PubMed ID: 25535281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dcn1 functions as a scaffold-type E3 ligase for cullin neddylation.
    Kurz T; Chou YC; Willems AR; Meyer-Schaller N; Hecht ML; Tyers M; Peter M; Sicheri F
    Mol Cell; 2008 Jan; 29(1):23-35. PubMed ID: 18206966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characterization and subcellular localization of Carassius auratus interferon regulatory factor-1.
    Shi Y; Zhang YB; Zhao Z; Jiang J; Zhang QY; Gui JF
    Dev Comp Immunol; 2008; 32(2):134-46. PubMed ID: 17604835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon regulatory factor 1 binding to p300 stimulates DNA-dependent acetylation of p53.
    Dornan D; Eckert M; Wallace M; Shimizu H; Ramsay E; Hupp TR; Ball KL
    Mol Cell Biol; 2004 Nov; 24(22):10083-98. PubMed ID: 15509808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CHIP functions an E3 ubiquitin ligase of Runx1.
    Shang Y; Zhao X; Xu X; Xin H; Li X; Zhai Y; He D; Jia B; Chen W; Chang Z
    Biochem Biophys Res Commun; 2009 Aug; 386(1):242-6. PubMed ID: 19524548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antagonists induce a conformational change in cIAP1 that promotes autoubiquitination.
    Dueber EC; Schoeffler AJ; Lingel A; Elliott JM; Fedorova AV; Giannetti AM; Zobel K; Maurer B; Varfolomeev E; Wu P; Wallweber HJ; Hymowitz SG; Deshayes K; Vucic D; Fairbrother WJ
    Science; 2011 Oct; 334(6054):376-80. PubMed ID: 22021857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon regulatory factor-1 (IRF-1) interacts with regulated in development and DNA damage response 2 (REDD2) in the cytoplasm of mouse bone marrow cells.
    Gupta M; Rath PC
    Int J Biol Macromol; 2014 Apr; 65():41-50. PubMed ID: 24412152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening ubiquitin specific protease activities using chemically synthesized ubiquitin and ubiquitinated peptides.
    Bacchi M; Fould B; Jullian M; Kreiter A; Maurras A; Nosjean O; Coursindel T; Puget K; Ferry G; Boutin JA
    Anal Biochem; 2017 Feb; 519():57-70. PubMed ID: 27993553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A model of the three-dimensional structure of human interferon responsive factor 1 and its modifications upon phosphorylation or phosphorylation-mimicking mutations.
    Storchi L; Remoli AL; Marsili G; Acchioni C; Acchioni M; Battistini A; Sgarbanti M; Marrone A
    J Biomol Struct Dyn; 2019 Oct; 37(17):4632-4643. PubMed ID: 30569833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel repressor domain is required for maximal growth inhibition by the IRF-1 tumor suppressor.
    Eckert M; Meek SE; Ball KL
    J Biol Chem; 2006 Aug; 281(32):23092-102. PubMed ID: 16679314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.